ODDB.org: Open Drug Database

Perenterol Lyo-Sol, polvere per sospensione orale - 10

Swissmedic Key	68559001	Registration Holder	Zambon Svizzera SA
Name	Perenterol Lyo-Sol, polvere per sospensione orale	Date of registration	16.05.2023
		Introduction of Sequence	16.05.2023
ATC-Classification	Saccharomyces Boulardii (A07FA02)	Revision date
WHO	WHO-DDD	Valid until	15.05.2028
Index Therapeuticus (BSV)		Show package size	10
Index Therapeuticus (Swissmedic)	04.09.	Description
Swissmedic categorie.	D
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680685590015	Medication Code	Phytoarzneimittel
Pharmacode		Disponibility

Composition

Polvere: saccharomyces boulardii cryodesiccatus (Saccharomyces boulardii CNCM I-745) 250 mg corresp. cellulae vivae 2*10^9 CFU, lactosum monohydricum 32.50 mg, pro vitro. Soluzione: fructosum 1520.0 mg, acidum citricum, aromatica (Beerenaroma) cum propylenglycolum 10.08 mg et alcohol benzylicus 1.2 mg et ethanolum 4.48 mg, E 202, natrii benzoas 8.0 mg corresp. natrium 1.272 mg, aqua purificata, ad solutionem pro 8 ml.

Packungsbestandteile

Galenic Form

Excipiens

Active Agent	Dose	additional_information
	250 mg correspond 2	Polvere

Inactive agents	Dose
Lactose Monohydrate	32.5 mg

Galenic Form

Excipiens

Inactive agents	Dose	additional_information
Citric Acid
Alcohol Benzylicus	1.2mg / 8ml
Aqua Purificata
	10.08mg / 8ml
		conserv.
Ethanol	4.48mg / 8ml
Fructosum	1520mg / 8ml	Soluzione
Sodium Benzoate	8mg / 8ml

Source

Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH